ServiceNow Eyes $7B Armis Acquisition to Boost Cybersecurity Arsenal
ServiceNow is in advanced talks to acquire cybersecurity startup Armis for up to $7 billion, marking its largest deal yet as tech giants race to strengthen security offerings.
NOTRELOAD AI
FDA Approves CARDAMYST: First Self-Administered Nasal Spray for PSVT
Milestone's (MIST) CARDAMYST nasal spray is FDA-approved for adults with PSVT (fast heart rate episodes). It's the first quick, self-administered home treatment.
Anavex Faces Setback in EU Alzheimer's Drug Review
Anavex Life Sciences receives negative EU opinion for blarcamesine Alzheimer's treatment but plans to request re-examination with new reviewers.
LENZ Stock Plunges After Retinal Tear Case Linked to VIZZ Eye Drops
LENZ Therapeutics shares dropped 27% following reports of a retinal tear associated with VIZZ presbyopia treatment, raising investor safety concerns despite company reassurances.
Fermi Shares Crash After Losing $150M Funding Deal
Fermi's stock plummeted 35% Friday after a potential tenant terminated a $150 million funding agreement for its Texas data center project, raising concerns for the newly public company.
Oracle Delays OpenAI Data Centers to 2028 Amid Shortages
Oracle pushes back completion of massive OpenAI data centers by one year to 2028, citing labor and material shortages in $300B cloud computing deal.